WILLIAM CRAIN: Open Payments
NPI 1649890286 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 63 payments from 13 companies in 2025. Trend: 2023 $3,200 · 2024 $865 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $286 |
| Corium, LLC | 12 | $204 |
| Alkermes, Inc. | 7 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Almatica Pharma LLC | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: VRAYLAR, Azstarys, ARISTADA, CAPLYTA, LOREEV XR, Auvelity, REXULTI, AUSTEDO XR.
Industry payments across AL — which companies pay providers there.
